Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

Data as of 3:59pm ET
 +0.03 / +4.23%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues75.0K0.000.000.00
Depreciation And Amortization50.7K45.1K42.4K37.1K
Operating ExpensesGross Income24.3K-45.1K-42.4K-37.1K
General Expenses--16.1M6.1M7.9M
Other Operating Expenses--0.00431.1K0.00
Research And Development--12.0M3.4M3.3M
Total Operating Expenses--16.1M6.6M8.0M
Non-Operating ExpensesOperating Income---16.1M-6.6M-8.0M
Extraordinary Credit--4.8M663.9K0.00
Extraordinary Charge--0.00-332.1K-1.4M
Other Expenses---101.6K0.00-204.2K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.0M-11.3M-6.2M-9.5M
Net Income-14.0M-11.3M-6.2M-9.5M
Shares To Calculate EPSShares To Calculate EPS78.7M93.0M97.1M128.6M
Shares To Calculate EPS Diluted78.7M93.0M97.1M128.6M
Earnings Per ShareEPS-$0.18-$0.12-$0.06-$0.07
EPS Diluted-$0.18-$0.12-$0.06-$0.07

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.